J.‐M. VIERFOND

1.2k total citations
36 papers, 931 citations indexed

About

J.‐M. VIERFOND is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.‐M. VIERFOND has authored 36 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.‐M. VIERFOND's work include Cystic Fibrosis Research Advances (7 papers), Synthesis and Biological Evaluation (7 papers) and Synthesis and Reactions of Organic Compounds (7 papers). J.‐M. VIERFOND is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Synthesis and Biological Evaluation (7 papers) and Synthesis and Reactions of Organic Compounds (7 papers). J.‐M. VIERFOND collaborates with scholars based in France, Italy and United Kingdom. J.‐M. VIERFOND's co-authors include Yvette Mettey, Frédéric Becq, Laurent Meijer, Bernard Fauconneau, Alain Piriou, Laurence Barrier, Hervé Galons, Marc Blondel, Stéphane Bach and Luis J. V. Galietta and has published in prestigious journals such as Nature Biotechnology, Journal of Cell Science and Journal of Medicinal Chemistry.

In The Last Decade

J.‐M. VIERFOND

34 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.‐M. VIERFOND France 14 386 357 231 84 76 36 931
Yvette Mettey France 17 527 1.4× 182 0.5× 397 1.7× 153 1.8× 65 0.9× 36 1.1k
Bruce J. Hrnjez United States 17 316 0.8× 226 0.6× 54 0.2× 49 0.6× 64 0.8× 23 708
Gary A. Flynn United States 19 653 1.7× 441 1.2× 80 0.3× 31 0.4× 128 1.7× 51 1.1k
Kumi Sato Japan 14 205 0.5× 292 0.8× 115 0.5× 216 2.6× 54 0.7× 39 930
Choong Leol Yoo United States 11 936 2.4× 174 0.5× 127 0.5× 148 1.8× 40 0.5× 13 1.3k
Masahiro Ohno Japan 15 282 0.7× 114 0.3× 43 0.2× 35 0.4× 57 0.8× 61 656
L. Mester France 17 281 0.7× 162 0.5× 59 0.3× 41 0.5× 50 0.7× 72 748
Donald T. Pals United States 18 690 1.8× 388 1.1× 60 0.3× 92 1.1× 98 1.3× 45 1.3k
Hazel J. Dyke United Kingdom 20 468 1.2× 382 1.1× 47 0.2× 84 1.0× 34 0.4× 30 911
Carola Gallo‐Rodriguez Argentina 24 1.1k 2.8× 963 2.7× 34 0.1× 88 1.0× 47 0.6× 48 1.9k

Countries citing papers authored by J.‐M. VIERFOND

Since Specialization
Citations

This map shows the geographic impact of J.‐M. VIERFOND's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐M. VIERFOND with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐M. VIERFOND more than expected).

Fields of papers citing papers by J.‐M. VIERFOND

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐M. VIERFOND. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐M. VIERFOND. The network helps show where J.‐M. VIERFOND may publish in the future.

Co-authorship network of co-authors of J.‐M. VIERFOND

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐M. VIERFOND. A scholar is included among the top collaborators of J.‐M. VIERFOND based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐M. VIERFOND. J.‐M. VIERFOND is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bach, Stéphane, et al.. (2004). A single step synthesis of 6-aminophenanthridines from anilines and 2-chlorobenzonitriles. Tetrahedron. 60(21). 4705–4708. 20 indexed citations
2.
Bach, Stéphane, Nicolas Talarek, Thibault Andrieu, et al.. (2003). Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nature Biotechnology. 21(9). 1075–1081. 155 indexed citations
3.
Zegarra‐Moran, Olga, Leila Romio, Chiara Folli, et al.. (2002). Correction of G551D‐CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB‐07. British Journal of Pharmacology. 137(4). 504–512. 49 indexed citations
4.
Olivier, Jean‐Christophe, et al.. (2002). Photodegradation study of a new activator of the cystic fibrosis chloride channel, the 6‐hydroxy‐10‐chlorobenzo[c]quinolizinium chloride (MPB‐07). Journal of Pharmaceutical Sciences. 91(2). 324–330. 1 indexed citations
5.
Mettey, Yvette, Marie Gompel, Matthieu Garnier, et al.. (2002). Aloisines, a New Family of CDK/GSK-3 Inhibitors. SAR Study, Crystal Structure in Complex with CDK2, Enzyme Selectivity, and Cellular Effects. Journal of Medicinal Chemistry. 46(2). 222–236. 126 indexed citations
6.
Dérand, Renaud, Yvette Mettey, Olga Zegarra‐Moran, et al.. (2001). Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation. American Journal of Physiology-Cell Physiology. 281(5). C1657–C1666. 40 indexed citations
7.
Dérand, Renaud, Yvette Mettey, Thierry Métayé, et al.. (2000). Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells. American Journal of Physiology-Cell Physiology. 279(6). C1925–C1937. 28 indexed citations
8.
Chappe, Valérie, Yvette Mettey, J.‐M. VIERFOND, et al.. (1998). Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel. British Journal of Pharmacology. 123(4). 683–693. 53 indexed citations
9.
Huguet, François, et al.. (1997). Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Pefloxacin and Norfloxacin in Rats. Journal of Pharmacology and Experimental Therapeutics. 280(2). 983–987. 26 indexed citations
10.
Loiseau, Philippe M., Yvette Mettey, & J.‐M. VIERFOND. (1996). Antifilarial and trypanocidal properties of phenothiazines and related polycyclics as new lead structures. International Journal for Parasitology. 26(10). 1115–1117. 14 indexed citations
11.
VIERFOND, J.‐M., et al.. (1994). A Synthesis of 2-Substituted Phenylbenzothiazoles. Heterocycles. 38(5). 1001–1001. 8 indexed citations
12.
Viossat, Β., et al.. (1994). Dichloro(2,5-diphényl-3,4-di-2-pyridyl-1H-pyrrole-N,N')cobalt(II). Acta Crystallographica Section C Crystal Structure Communications. 50(2). 211–214. 3 indexed citations
13.
VIERFOND, J.‐M. & Yvette Mettey. (1993). A Novel Synthetic Route to Cyanophenothiazines. First Example of Smiles Rearrangement from Halogenobenzonitriles. Heterocycles. 36(5). 987–987. 5 indexed citations
14.
15.
VIERFOND, J.‐M., et al.. (1990). SYNTHESIS, STRUCTURE ACTIVITY RELATIONSHIP AND PHARMACOLOGY OF THIENOISOTHIAZOLO[ 3,4-B]QUINOXALINES. 25. 251–255. 1 indexed citations
16.
MIOCQUE, M., et al.. (1989). Annelation of Quinoxaline by Sulfur Stabilized Carbanions. Heterocycles. 29(1). 141–141. 4 indexed citations
17.
VIERFOND, J.‐M., et al.. (1989). Reactions selectives de l'o.chlorobenzontrile : SNAr. Tetrahedron Letters. 30(8). 935–936. 3 indexed citations
18.
Labidalle, Serge, H. MOSKOWITZ, J.‐M. VIERFOND, et al.. (1988). Analogues morphiniques derives des tetra- et hexahydrodibenzofurannes. Tetrahedron. 44(4). 1171–1186. 9 indexed citations
19.
Mettey, Yvette & J.‐M. VIERFOND. (1986). Action du phényllithium en série pyrazine: Piégeage des intermédiaires réactionnels par le benzoate de méthyle. Journal of Heterocyclic Chemistry. 23(4). 1051–1054. 4 indexed citations
20.
Mettey, Yvette, et al.. (1983). Action d'organolithiens sur la méthyl‐2 quinoxaline. Etude de la réactivité des adduits. Journal of Heterocyclic Chemistry. 20(1). 133–137. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvette Mettey Breakdown of academic impact, for papers by Bruce J. Hrnjez Breakdown of academic impact, for papers by Gary A. Flynn Breakdown of academic impact, for papers by Kumi Sato Breakdown of academic impact, for papers by Choong Leol Yoo Breakdown of academic impact, for papers by Masahiro Ohno Breakdown of academic impact, for papers by L. Mester Breakdown of academic impact, for papers by Donald T. Pals Breakdown of academic impact, for papers by Hazel J. Dyke Breakdown of academic impact, for papers by Carola Gallo‐Rodriguez
Rankless by CCL
2026